Empfield James R.

EVP, Drug Discovery at XENE

Sold, on record
$3.8M
Dollars the filings state
Form 4 sales
2
Latest Aug 12, 2022
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • XENEXenon Pharmaceuticals Inc.EVP, Drug Discovery

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale XENEUnusual
    Mar 7, 2022 2022

    Sold 51,168 shares at $30.63 ($1.6M)

    Empfield James R., EVP, Drug Discovery

    Sold 83.7% of holdings ($1.9M position)10,000 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale XENEUnusual
    Aug 12, 2022 +158 days

    Sold 57,743 shares at $38.31 ($2.2M)

    Empfield James R., EVP, Drug Discovery

    Sold 85.2% of holdings ($2.6M position)10,000 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Empfield James R.
Source
Aug 12, 2022Aug 16, 2022XENEEVP, Drug DiscoveryForm 4 sale57,743$2.2M85.2%UnusualSEC
Mar 7, 2022Mar 8, 2022XENEEVP, Drug DiscoveryForm 4 sale51,168$1.6M83.7%UnusualSEC